William Ringo
Voorzitter bij ASSEMBLY BIOSCIENCES, INC.
Vermogen: 35 394 $ op 30-04-2024
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Kevin Hammons | M | 58 | 27 jaar | |
Susan Mahony | M | 59 |
Kovina Therapeutics, Inc.
Kovina Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Kovina Therapeutics, Inc. is a pre-clinical stage biotechnology company based in Indianapolis, IN. The company has assembled a team of scientists and industry leaders with expertise in HPV and small molecule drug design to advance its pipeline of drug candidates. Kovina Therapeutics is developing first-in-class anti-viral therapeutics to treat human papillomavirus (HPV) related infections and associated cancers. The company was founded by Samy Meroueh, Zhijian Lu, Elliot Androphy. Kristin T. Sherman has been the CEO of the company since 2021. | 24 jaar |
Jason Okazaki | M | 48 | 4 jaar | |
David Ricks | M | 56 | 28 jaar | |
Bruce Given | M | 69 |
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX.
InCube Venture Partners LLC
InCube Venture Partners LLC Investment ManagersFinance InCube Ventures Partners LLC (InCube Ventures) is a venture capital firm founded in 2008 by Mir Imran. The firm is headquartered in San Jose, California. | 10 jaar |
Wayne Smith | M | 78 | 27 jaar | |
Erin Colgan | F | 43 | 4 jaar | |
Elliot Androphy | M | - |
Kovina Therapeutics, Inc.
Kovina Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Kovina Therapeutics, Inc. is a pre-clinical stage biotechnology company based in Indianapolis, IN. The company has assembled a team of scientists and industry leaders with expertise in HPV and small molecule drug design to advance its pipeline of drug candidates. Kovina Therapeutics is developing first-in-class anti-viral therapeutics to treat human papillomavirus (HPV) related infections and associated cancers. The company was founded by Samy Meroueh, Zhijian Lu, Elliot Androphy. Kristin T. Sherman has been the CEO of the company since 2021. | - |
Alexander Macrae | M | 61 | 8 jaar | |
John Celebi | M | 52 | 6 jaar | |
John McHutchison | M | 66 | 5 jaar | |
H. Parker | F | 68 | 10 jaar | |
Rita Karachun | F | 61 | 5 jaar | |
Caroline Litchfield | F | 55 | 5 jaar | |
Heather Wasserman | M | - | 4 jaar | |
James Peyer | M | 37 | 4 jaar | |
Kristian Humer | M | 49 | 3 jaar | |
Jeffrey R. Latts | M | 76 |
Allos Therapeutics, Inc.
Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | 17 jaar |
Lisa Johnson-Pratt | M | 60 | 3 jaar | |
Edward van der Horst | M | 51 | 5 jaar | |
Jon Filderman | M | - | 5 jaar | |
Jessie English | M | 60 | 3 jaar | |
Zhijian Lu | M | - |
Kovina Therapeutics, Inc.
Kovina Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Kovina Therapeutics, Inc. is a pre-clinical stage biotechnology company based in Indianapolis, IN. The company has assembled a team of scientists and industry leaders with expertise in HPV and small molecule drug design to advance its pipeline of drug candidates. Kovina Therapeutics is developing first-in-class anti-viral therapeutics to treat human papillomavirus (HPV) related infections and associated cancers. The company was founded by Samy Meroueh, Zhijian Lu, Elliot Androphy. Kristin T. Sherman has been the CEO of the company since 2021. | - |
John O. Gunderson | M | - | 2 jaar | |
Christopher Gerry | M | - | 2 jaar | |
Alonzo Weems | M | - | 27 jaar | |
Kristin Sherman | F | - |
Kovina Therapeutics, Inc.
Kovina Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Kovina Therapeutics, Inc. is a pre-clinical stage biotechnology company based in Indianapolis, IN. The company has assembled a team of scientists and industry leaders with expertise in HPV and small molecule drug design to advance its pipeline of drug candidates. Kovina Therapeutics is developing first-in-class anti-viral therapeutics to treat human papillomavirus (HPV) related infections and associated cancers. The company was founded by Samy Meroueh, Zhijian Lu, Elliot Androphy. Kristin T. Sherman has been the CEO of the company since 2021. | 3 jaar |
Deneen Vojta | M | 59 | 3 jaar | |
Edward W. Lomicka | M | - | 22 jaar | |
Andrew Richard Boyce | M | 62 |
Atlantic Healthcare Plc
Atlantic Healthcare Plc Pharmaceuticals: MajorHealth Technology Atlantic Healthcare Plc operates as holding company with interest in pharmaceutical. Its products include Alicaforsen Enema, an anti-inflammatory intercellular adhesion molecule inhibitor that acts by inhibiting a key protein in the inflammation process. The firm offers its product for the treatment of pouchitis and ulcerative colitis. The company was founded by Toby Wilson Waterworth and Fiona Mary Wilson Waterworth in 2006 and is headquartered in Saffron Walden, the United Kingdom. | 12 jaar |
Martin G. Schweinhart | M | 68 | 27 jaar | |
Robert Carey | M | 65 | 8 jaar | |
Andrew Farquharson | M | 55 |
InCube Venture Partners LLC
InCube Venture Partners LLC Investment ManagersFinance InCube Ventures Partners LLC (InCube Ventures) is a venture capital firm founded in 2008 by Mir Imran. The firm is headquartered in San Jose, California. | 17 jaar |
Thomas Ricks | M | 71 | 9 jaar | |
Michael Houghton | M | 73 | 3 jaar | |
Bob Holmen | M | 60 | 7 jaar | |
Mir Imran | M | 67 |
InCube Venture Partners LLC
InCube Venture Partners LLC Investment ManagersFinance InCube Ventures Partners LLC (InCube Ventures) is a venture capital firm founded in 2008 by Mir Imran. The firm is headquartered in San Jose, California. | 17 jaar |
Anthony Altig | M | 68 | 12 jaar | |
Peter Hutt | M | 89 |
InCube Venture Partners LLC
InCube Venture Partners LLC Investment ManagersFinance InCube Ventures Partners LLC (InCube Ventures) is a venture capital firm founded in 2008 by Mir Imran. The firm is headquartered in San Jose, California. | - |
Earl Collier | M | 76 |
InCube Venture Partners LLC
InCube Venture Partners LLC Investment ManagersFinance InCube Ventures Partners LLC (InCube Ventures) is a venture capital firm founded in 2008 by Mir Imran. The firm is headquartered in San Jose, California. | - |
Gina Consylman | F | 52 | 4 jaar | |
Jeanette Bjorkquist | F | - | 5 jaar | |
William Delaney | M | 52 | 4 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Thomas Wiggans | M | 72 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 15 jaar |
John Lechleiter | M | 70 | 38 jaar | |
Derek Small | M | 48 | 6 jaar | |
Aron M. Knickerbocker | M | 54 | 10 jaar | |
Edward O. Lanphier | M | 67 | 22 jaar | |
Brian Atwood | M | 71 | 14 jaar | |
Lewis Williams | M | 74 | 18 jaar | |
Michael Samar | M | 51 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 6 jaar |
Mark McDade | M | 69 | 14 jaar | |
George Cole | M | 75 |
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | 3 jaar |
David Barrett | M | 48 | 8 jaar | |
James Rickey | M | 45 | 6 jaar | |
Daniel Welch | M | 66 | 12 jaar | |
Franklin Berger | M | 74 | 11 jaar | |
Rachel A. Seifert | F | 63 | 19 jaar | |
Russell Ellison | M | 76 | 5 jaar | |
Thomas Civik | M | 55 | 1 jaar | |
Kathy Yi | F | 52 | 2 jaar | |
Lori Lyons-Williams | F | 46 | 5 jaar | |
Martin Godbout | M | - | 12 jaar | |
Matthew Fust | M | 59 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 11 jaar |
Luis Borges | M | 62 | 5 jaar | |
Joseph Zakrzewski | M | 60 | 22 jaar | |
Daljit Singh Aurora | M | 55 | 5 jaar | |
Christopher Whitmore | M | - | 3 jaar | |
R. Lee Douglas | M | 72 | 15 jaar | |
Bryce D. Carmine | M | 72 | 29 jaar | |
Garry Nicholson | M | 69 | 12 jaar | |
Carlos Paya | M | 65 | 8 jaar | |
Uri Lopatin | M | 52 | 17 jaar | |
Toby Wilson Waterworth | M | - |
Atlantic Healthcare Plc
Atlantic Healthcare Plc Pharmaceuticals: MajorHealth Technology Atlantic Healthcare Plc operates as holding company with interest in pharmaceutical. Its products include Alicaforsen Enema, an anti-inflammatory intercellular adhesion molecule inhibitor that acts by inhibiting a key protein in the inflammation process. The firm offers its product for the treatment of pouchitis and ulcerative colitis. The company was founded by Toby Wilson Waterworth and Fiona Mary Wilson Waterworth in 2006 and is headquartered in Saffron Walden, the United Kingdom. | 16 jaar |
Kapil Dhingra | M | 64 | 10 jaar | |
David J. Scott | M | 71 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | - |
Mark Gergen | M | 61 | 3 jaar | |
Randall L. Tobias | M | - | 12 jaar | |
Pablo Cagnoni | M | 60 |
Allos Therapeutics, Inc.
Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO.
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 5 jaar |
David McWilliams | M | 80 |
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | 10 jaar |
Richard DiMarchi | M | 71 | 21 jaar | |
Graham Cooper | M | 54 | 1 jaar | |
Francis Sarena | M | 53 | 11 jaar | |
Freda Lewis-Hall | M | 69 | 20 jaar | |
David Lewis Miller | M | 74 | 19 jaar | |
Amy Schulman | F | 63 | 6 jaar | |
David Baltimore | M | 86 | 22 jaar | |
Edward Penhoet | M | 83 | 11 jaar | |
W. Cash | M | 75 | 20 jaar | |
Henry Ward Wolff | M | 75 |
Abgenix, Inc.
Abgenix, Inc. BiotechnologyHealth Technology Abgenix, Inc. developed therapeutic products. It focused on the discovery, development and manufacturing of therapeutic antibodies. The firm's antibody development platform included manufacturing fully human antibody product candidates to a variety of disease targets. The company was founded by R. Scott Greer in 1996 and was headquartered in Fremont, CA. | 13 jaar |
Frances Fergusson | M | 79 | 9 jaar | |
Stephen W. Sanger | M | 78 | 9 jaar | |
Kathi P. Seifert | F | 74 | 26 jaar | |
Martin MacKay | M | 68 | 14 jaar | |
Joseph M. Spagnardi | M | 60 |
Inspire Pharmaceuticals, Inc.
Inspire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Inspire Pharmaceuticals, Inc. operated as a biopharmaceutical company. It discovered and developed pharmaceutical products to treat diseases that results from deficiencies in the body's natural mechanisms of mucosal hydration. The company was founded by Kendall Harden, Richard C. Boucher, Andre L. Lamotte, H. Jefferson Leighton and Terrance G. McGuire and was headquartered in Whitehouse Station, NJ. | - |
Paul Goddard | M | 74 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 16 jaar |
Deirdre Connelly | F | 63 | 26 jaar | |
Thomas Staab | M | 56 |
Inspire Pharmaceuticals, Inc.
Inspire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Inspire Pharmaceuticals, Inc. operated as a biopharmaceutical company. It discovered and developed pharmaceutical products to treat diseases that results from deficiencies in the body's natural mechanisms of mucosal hydration. The company was founded by Kendall Harden, Richard C. Boucher, Andre L. Lamotte, H. Jefferson Leighton and Terrance G. McGuire and was headquartered in Whitehouse Station, NJ. | 8 jaar |
Joseph Schachle | M | 59 |
Inspire Pharmaceuticals, Inc.
Inspire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Inspire Pharmaceuticals, Inc. operated as a biopharmaceutical company. It discovered and developed pharmaceutical products to treat diseases that results from deficiencies in the body's natural mechanisms of mucosal hydration. The company was founded by Kendall Harden, Richard C. Boucher, Andre L. Lamotte, H. Jefferson Leighton and Terrance G. McGuire and was headquartered in Whitehouse Station, NJ. | - |
Gregory J. Mossinghoff | M | - |
Inspire Pharmaceuticals, Inc.
Inspire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Inspire Pharmaceuticals, Inc. operated as a biopharmaceutical company. It discovered and developed pharmaceutical products to treat diseases that results from deficiencies in the body's natural mechanisms of mucosal hydration. The company was founded by Kendall Harden, Richard C. Boucher, Andre L. Lamotte, H. Jefferson Leighton and Terrance G. McGuire and was headquartered in Whitehouse Station, NJ. | 7 jaar |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Verenigde Staten | 98 | 98.00% |
Verenigd Koninkrijk | 2 | 2.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- William Ringo
- Persoonlijk netwerk